Newsfeeds - Spark Newswire

4 minute read

Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

February 21, 3:07 PM

Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.

AKAN

1 minute read

Why Chemomab Therapeutics Shares Are Trading Higher Today

By Ye Kuang

February 21, 2:10 PM

Chemomab Therapeutics Ltd (NASDAQ: CMMB) shares are trading higher on Tuesday after the company announced FDA clearance of its Investigational New Drug Application to evaluate CM-101 in a Phase 2 trial in

CMMB

1 minute read

FDA Gives Green Signal To Chemomab Therapeutics’ Rare Disease Study

By Vandana Singh

February 21, 12:46 PM

The FDA has signed off Chemomab Therapeutics Ltd’s (NASDAQ:CMMB) Investigational New Drug (IND) Application to evaluate CM-101 in a Phase 2…

CMMB

4 minute read

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

January 4, 2:17 PM

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.

AIM

4 minute read

Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

January 3, 2:39 PM

Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.

ACMR

1 minute read

Chemomab Shares Surge After Positive Data From NASH Biomarker Trial

By Vandana Singh

January 3, 11:27 AM

Chemomab Therapeutics Ltd (NASDAQ: CMMB) reported topline results from its Phase 2a trial assessing CM-101 in non-alcoholic steatohepatitis (NASH) patients.

CMMB

2 minute read

Wall Street Starts 2023 On Positive Note

By Lisa Levin

January 3, 10:57 AM

U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Tuesday.

ATNF

1 minute read

Chemomab Therapeutics Announced Independent Data Monitoring Committee Said Had No Safety Concerns With Proceeding With Adding a Planned 20 Milligram Per Kilogram (Mg/kg) Dosing Cohort to the Psc Trial

By Charles Gross

December 21, 8:04 AM

Chemomab Therapeutics, Ltd.

CMMB

5 minute read

Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

December 12, 2:05 PM

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.

ACET